212 related articles for article (PubMed ID: 28387927)
1. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
2. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Lopes Pegna A; Picozzi G; Falaschi F; Carrozzi L; Falchini M; Carozzi FM; Pistelli F; Comin C; Deliperi A; Grazzini M; Innocenti F; Maddau C; Vella A; Vaggelli L; Paci E; Mascalchi M;
J Thorac Oncol; 2013 Jul; 8(7):866-75. PubMed ID: 23612465
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
5. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
[TBL] [Abstract][Full Text] [Related]
6. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
[TBL] [Abstract][Full Text] [Related]
7. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
[TBL] [Abstract][Full Text] [Related]
9. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
[TBL] [Abstract][Full Text] [Related]
10. Initial LDCT appearance of incident lung cancers in the ITALUNG trial.
Mascalchi M; Picozzi G; Falchini M; Vella A; Diciotti S; Carrozzi L; Pegna AL; Falaschi F
Eur J Radiol; 2014 Nov; 83(11):2080-6. PubMed ID: 25174775
[TBL] [Abstract][Full Text] [Related]
11. miR-Test: a blood test for lung cancer early detection.
Montani F; Marzi MJ; Dezi F; Dama E; Carletti RM; Bonizzi G; Bertolotti R; Bellomi M; Rampinelli C; Maisonneuve P; Spaggiari L; Veronesi G; Nicassio F; Di Fiore PP; Bianchi F
J Natl Cancer Inst; 2015 Jun; 107(6):djv063. PubMed ID: 25794889
[TBL] [Abstract][Full Text] [Related]
12. A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT).
Wang X; Zhi X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Shen D; Zheng C; Zhao D; Yang S; Qi J; Xin H; Stojadinovic A; Avital I; Lee LJ; Rao J; Zhang W
Oncotarget; 2017 Jul; 8(28):45345-45355. PubMed ID: 28514755
[TBL] [Abstract][Full Text] [Related]
13. Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors.
Puliti D; Mascalchi M; Carozzi FM; Carrozzi L; Falaschi F; Paci E; Lopes Pegna A; Aquilini F; Barchielli A; Bartolucci M; Grazzini M; Picozzi G; Pistelli F; Rosselli A; Zappa M;
Lung Cancer; 2019 Dec; 138():72-78. PubMed ID: 31654837
[TBL] [Abstract][Full Text] [Related]
14. Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis.
Carozzi FM; Bisanzi S; Falini P; Sani C; Venturini G; Lopes Pegna A; Bianchi R; Ronchi C; Picozzi G; Mascalchi M; Carrozzi L; Baliva F; Pistelli F; Tavanti L; Falaschi F; Grazzini M; Innocenti F; Paci E;
Lung Cancer; 2010 May; 68(2):216-21. PubMed ID: 19646775
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.
Sozzi G; Boeri M; Rossi M; Verri C; Suatoni P; Bravi F; Roz L; Conte D; Grassi M; Sverzellati N; Marchiano A; Negri E; La Vecchia C; Pastorino U
J Clin Oncol; 2014 Mar; 32(8):768-73. PubMed ID: 24419137
[TBL] [Abstract][Full Text] [Related]
16. [Risk factors for lung cancer based on low-dose computed tomography screening].
Jin YJ; Tang W; Huang Y; Wang JW; Hou DH; Qi LL; Zhao SJ; Wu N
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):222-227. PubMed ID: 32252201
[No Abstract] [Full Text] [Related]
17. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.
Infante M; Cavuto S; Lutman FR; Brambilla G; Chiesa G; Ceresoli G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Errico V; Inzirillo F; Bottoni E; Voulaz E; Alloisio M; Destro A; Roncalli M; Santoro A; Ravasi G;
Am J Respir Crit Care Med; 2009 Sep; 180(5):445-53. PubMed ID: 19520905
[TBL] [Abstract][Full Text] [Related]
18. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study.
Veronesi G; Maisonneuve P; Bellomi M; Rampinelli C; Durli I; Bertolotti R; Spaggiari L
Ann Intern Med; 2012 Dec; 157(11):776-84. PubMed ID: 23208167
[TBL] [Abstract][Full Text] [Related]
19. [Value of low-dose spiral computed tomography in lung cancer screening].
Zhang Y; Hong QY; Shi WB; Ou JX; Yang DW; Hu J; Bai CX; Zeng MS; Chen G
Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3011-4. PubMed ID: 24417917
[TBL] [Abstract][Full Text] [Related]
20. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
